Smith & Nephew (SNN) Upgraded to Hold by Deutsche Bank

Share on StockTwits

Deutsche Bank upgraded shares of Smith & Nephew (NYSE:SNN) from a sell rating to a hold rating in a research note issued to investors on Friday morning, The Fly reports.

Several other equities research analysts have also commented on the stock. Zacks Investment Research upgraded shares of Smith & Nephew from a hold rating to a buy rating and set a $42.00 price objective on the stock in a research report on Wednesday. Canaccord Genuity reiterated a buy rating on shares of Smith & Nephew in a research report on Thursday, November 1st. Finally, HSBC lowered shares of Smith & Nephew from a buy rating to a hold rating in a research report on Tuesday, October 16th. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average price target of $42.00.

Shares of NYSE SNN traded up $0.72 during trading on Friday, hitting $37.93. 963,436 shares of the company were exchanged, compared to its average volume of 472,477. The firm has a market capitalization of $16.27 billion, a P/E ratio of 19.96, a PEG ratio of 3.02 and a beta of 0.60. Smith & Nephew has a 1 year low of $32.22 and a 1 year high of $39.85. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 2.13.

Several institutional investors have recently added to or reduced their stakes in SNN. Checchi Capital Advisers LLC purchased a new stake in shares of Smith & Nephew in the 2nd quarter worth about $204,000. Quantbot Technologies LP purchased a new stake in shares of Smith & Nephew in the 3rd quarter worth about $204,000. Capital Fund Management S.A. purchased a new stake in shares of Smith & Nephew in the 2nd quarter worth about $210,000. Avestar Capital LLC boosted its position in shares of Smith & Nephew by 25.8% in the 3rd quarter. Avestar Capital LLC now owns 7,910 shares of the medical equipment provider’s stock worth $276,000 after buying an additional 1,623 shares in the last quarter. Finally, Alps Advisors Inc. purchased a new stake in shares of Smith & Nephew in the 2nd quarter worth about $302,000. Institutional investors and hedge funds own 9.03% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Article: Book Value Per Share in Stock Trading

The Fly

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.